Lipid-Lowering Efficacy and Safety of a New Generic Rosuvastatin in Koreans: an 8-Week Randomized Comparative Study with a Proprietary Rosuvastatin.
Eui-Young ChoiChan Joo LeeDoonghoon ChoiByeong-Keuk KimIn Cheol KimJung-Sun KimChul-Min AhnGeu Ru HongIn-Jeong ChoChi Young ShimSang-Hak LeePublished in: Journal of lipid and atherosclerosis (2020)
ClinicalTrials.gov Identifier: NCT03949374.